APA (7th ed.) Citation

Simon, T., Bhatt, D. L., Bergougnan, L., Farenc, C., Pearson, K., Perrin, L., . . . Dubar, M. (2011). Genetic polymorphisms and the impact of a higher clopidogrel dose regimen on active metabolite exposure and antiplatelet response in healthy subjects. Clinical pharmacology and therapeutics, 90(2), 287. https://doi.org/10.1038/clpt.2011.127

Chicago Style (17th ed.) Citation

Simon, T., et al. "Genetic Polymorphisms and the Impact of a Higher Clopidogrel Dose Regimen on Active Metabolite Exposure and Antiplatelet Response in Healthy Subjects." Clinical Pharmacology and Therapeutics 90, no. 2 (2011): 287. https://doi.org/10.1038/clpt.2011.127.

MLA (9th ed.) Citation

Simon, T., et al. "Genetic Polymorphisms and the Impact of a Higher Clopidogrel Dose Regimen on Active Metabolite Exposure and Antiplatelet Response in Healthy Subjects." Clinical Pharmacology and Therapeutics, vol. 90, no. 2, 2011, p. 287, https://doi.org/10.1038/clpt.2011.127.